EchoStar shorts cover hard as earnings loom Thursday
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
EchoStar shed 13% of its short book in a single week, the most aggressive covering in months, even as the stock added 4.6% to close at $90.39 on Tuesday.
That covering move is statistically remarkable. ORTEX estimates put short interest at 15.3% of free float as of October 27, down from 17.4% last week and off the 19.6% level cited in notes from earlier this month. The weekly decline of nearly 13% is 2.1 standard deviations below the company's typical weekly short-interest move over the past year, meaning this is not routine position trimming. Shorts have returned roughly 3.2 million shares to the lending pool in a matter of days, a significant mechanical bid for the stock going into Thursday's Q3 earnings at 3pm ET. What makes the covering notable is the timing rather than the absolute level: at 15.3% of float, the short book remains large, but the direction of travel has shifted abruptly.
The lending market corroborates the covering story, though without urgency. Availability has tightened modestly to 163%, meaning lenders still hold nearly two shares available for every share currently borrowed. That is well above the 52-week low of 7.5%, which represents the tightest this borrow market has been over the past year. Cost to borrow has also eased, falling 15% on the week to 0.47%, a low figure that suggests no squeeze dynamic is forcing the covering. Shorts are choosing to reduce exposure ahead of results, not being squeezed out. Options positioning is similarly calm: the put/call ratio is 0.50, a fraction below its 20-day average and half a standard deviation below it, with no unusual defensive demand visible.
The Street has been directionally clear since the summer, and that consensus is now being tested by earnings. JP Morgan's October 16 two-notch flip from Underweight to Overweight with a $144 target was the most dramatic single action. Morgan Stanley assumed at Overweight ($134) in September. UBS upgraded to Buy ($150) in early September. Three bellwether firms, all Overweight or equivalent, all within six weeks. The consensus mean target of $130.20 implies 44% upside from the current price. TD Cowen and Citigroup trimmed targets to $130 and $117 respectively after August results but held Buy ratings, a signal of conviction trimmed at the margin rather than abandoned. The EPS surprise factor score ranks at the 95th percentile of the ORTEX universe, meaning the company has a strong track record of beating estimates. The analyst recommendation differential also ranks at the 97th percentile, reflecting how sharply the Street has moved toward the bullish side. Against that, EV/EBITDA of 27x is elevated, and the short score of 70.9, while it has drifted down from 72.4 two weeks ago, remains in the elevated range.
Charles Ergen's position is the structural backdrop to all of this. He holds a 13D activist filing on his own company, with the last disclosed stake at 50.9% of the class across his personal holding and the Ergen Family Trust combined. That concentration means more than half the voting power sits with one person going into a results call that multiple Wall Street firms have re-rated in the past six weeks. Secondary institutional holders have been building: Wellington added nearly a million shares in the August reporting period, Apollo added 1.8 million shares as of June 30, and Citadel increased its position by 2.9 million shares over the same period. These are not passive index flows. Stakes are as-last-disclosed around the 5% threshold; holders dropping below 5% may not file again.
The last two earnings prints produced clean beats. August's Q2 result moved the stock 8.9% on the day and added another 6% over the following five sessions. The prior print in August moved 2.4% on the day and 5.6% over five days. Both were positive. That history will frame how the short covering this week is read: a stock with a 95th-percentile EPS surprise track record, unanimous major-bank buy ratings, and 13% of the short book returning in one week going into a Thursday afternoon print is a setup worth watching closely, whatever the result.
The number to track Thursday is whether short interest continues its decline in the days after the print, or rebuilds toward the 17% to 19% range that has characterised the past few months.
Stocks in this article
See the live data behind this article on ORTEX.
Open ECHO on ORTEX →How this article was generated
- Generated
- 28 Oct 2026, 19:43
- Data as of
- 28 Oct 2026, 19:33
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.